EMPA-M 12.5/1000MG EMPAGLIFLOZIN /METFORMIN 14’S

Empa-M 12.5/1000mg is a combination medication containing Empagliflozin and Metformin, primarily used for the management of type 2 diabetes mellitus. This drug works by improving glycemic control in adults with diabetes, helping to lower blood sugar levels effectively.

Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, promotes the excretion of glucose through urine, while Metformin enhances insulin sensitivity and reduces hepatic glucose production. Together, they provide a dual mechanism of action that aids in better blood sugar management.

In addition to its primary use in diabetes management, Empa-M may also assist in weight loss and has cardiovascular benefits, making it a suitable choice for patients with type 2 diabetes who are at risk of heart disease.

In Kenya, Empa-M is gaining popularity among healthcare providers for its effectiveness and dual action in treating diabetes.